Schultz, SH, North, SW, Shields, CG.
Schizophrenia: a review.
Am Fam Physician
Hunt, MJ, Raynaud, B, Garcia, R.
Ketamine dose-dependently unduces high-frequency oscillations in the nucleus accumbens in freely moving rats.
Littlewood, CL, Jones, N, O'neill, MJ.
Mapping the central effects of ketamine in the rat using pharmacological MRI.
Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia.
J Neural Transm
New roles for an old enzyme: Na,K-ATPase emerges as an interesting drug target.
J Intern Med
Wyse, AT, Streck, EL, Worm, P, Wajner, A, Ritter, F, Netto, CA.
Preconditioning prevents the inhibition of Na+,K+-ATPase activity after brain ischemia.
Nanitsos, EK, Nguyen, KT, St'astný, F, Balcar, VJ.
Glutamatergic hypothesis of schizophrenia: involvement of Na+/K+-dependent glutamate transport.
J Biomed Sci
Hattori, N, Kitagawa, K, Higashida, T
CI-ATPase and Na+/K(+)-ATPase activities in Alzheimer's disease brains.
Zugno, AI, Valvassori, SS, Scherer, EB
Na+,K+-ATPase activity in an animal model of mania.
J Neural Transm
Canever, L, Oliveira, L, De Luca, R
A rodent model of schizophrenia reveals increase in creatine kinase activity with associated behavior changes.
Oxid Med and Cell Longevity
Oliveira, L, Fraga, DB, De Luca, RD
Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine.
Metab Brain Dis
Imre, G, Fokkema, DS, Den Boer, JA, Ter Horst, GJ.
Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity.
Brain Res Bull
Chan, KM, Delfert, DM, Koepnick, SL, McDonald, JM.
Effect of W7 on Ca2+ uptake and Ca2+-ATPase activities of the endoplasmic reticulum of rat liver.
Arch Biochem Biophys
Verma, A, Moghaddam, B.
NMDA receptor antagonists impair prefrontal cortex function as accessed via spatial delayed alternation performance in rats: modulation by dopamine.
Yamaguchi, I, Walk, SF, Jose, PA, Felder, RA.
Dopamine D2L receptors stimulate Na+/K(+)-ATPase activity in murine LTK- cells.
Snyder, GL, Fienberg, AA, Huganir, RL, Greengard, P.
A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor.
Ben-Shachar, D, Zuk, R, Gazawi, H, Ljubuncic, P.
Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders.
Volz, HR, Riehemann, S, Maurer, I
Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31) P chemical shift spectroscopic-imaging study.
Ben-Shachar, D, Nadri, C, Karry, G, Agam, G.
Mitochondrial complex I subunits are altered in rats with neonatal ventral hippocampal damage but not in rats exposed to oxygen restriction at neonatal age.
J Mol Neurosci
Schizoid neurochemical pathology-induced membrane Na(+)-K+ ATPase inhibition in relation to neurological disorders.
Int J Neurosci
Del Arco, A, Ronzoni, G, Mora, F.
Prefrontal stimulation of GABAA receptors counteracts the corticolimbic hyperactivity produced by NMDA antagonists in the prefrontal cortex of the rat.
Del Arco, A, Mora, F.
Glutamate-dopamine in vivo interaction in the prefrontal cortex modulates the release of dopamine and acetylcholine in the nucleus accumbens of the awake rat.
J Neural Transm
Corti, C, Xuereb, JH, Crepaldi, L, Corsi, M, Michielin, F, Ferraguti, F.
Altered levels of glutamatergic receptors and Na+/K+ ATPase α1 in the prefrontal cortex of subjects with schizophrenia.